ÂÜŔňÂŇÂ×

The Scientific and Research Team at iBio is responsible for the innovation and development of new biologics, including therapeutics and vaccines, to enhance human and animal health. This includes the design and execution of pharmacological studies, protein expression, downstream process development, and analytical assessments. Leveraging advanced technologies like machine learning and iBio's proprietary FastPharming™ and FastGlycaneering™ platforms, the team accelerates the production and scalability of biologics, ensuring efficient and rapid response to healthcare challenges such as COVID-19.